Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LoGTS: Brimonidine vs Timolol in Low-Pressure Glaucoma
NCT00317577Phase 2Completed
- Sponsor
- Chicago Center for Vision Research
- Start
- Dec 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brimonidine in normal tension glaucoma (NTG), sponsored by Chicago Center for Vision Research. Started Dec 1998; status: completed.
02
Drugs
brimonidine
03
Conditions
normal tension glaucoma (NTG)
Beyond the preview
Go deeper on NCT00317577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317577.